A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration

Author:

Jackson Timothy L.ORCID,Slakter Jason,Buyse Marc,Wang KunORCID,Dugel Pravin U.,Wykoff Charles C.ORCID,Boyer David S.ORCID,Gerometta Michael,Baldwin Megan E.,Price Clare F.ORCID,Kousal Bohdan,Studnicka Jan,Veith Michal,Creuzot-Garcher Catherine,De Bats Flore,Gaucher David,Mauget-Faysse Martine,Souied Eric,Tadayoni Ramin,Facsko Andrea,Kerénvi Agnes,Papp Andras,Tsorbatzoglou Alexis,Vogt Gabor,Barak Yoreh,Chowers Itay,Goldstein Michaella,Hanhart Joel,Morori-Katz Haya,Rosenblatt Irit,Rubowitz Alexander,Netzer Oren Tomkins,Bandello Francesco,Ciardella Antonio,Ricci Federico,Staurenghi Giovanni,Virgili Gianni,Baumane Kristine,Laganovska Guna,Ozolina Signe,Strautmane Ilze,Kaluzny Bartlomiej,Mackiewicz Jerzy,Misiuk-Hoilo Marta,Mrukwa-Kominek Ewa,Oleksy Piotr,Raczynska Krystyna,Zarnowski Tomasz,Adan Alfredo,Araiz Javier,Boixadera Anna,Fernández-Vega Alvaro,Layana Alfredo Garcia,Gomez-Ulla Francisco,Montero Javier,Ruiz Moreno Jose Maria,Gilmour David,Jackson Timothy,Liyanage Sidath,Membrey Luke,Menon Geeta,Narendran Niro,Sivaprasad Sobha,Alfaro Daniel,Antoszyk Andrew,Baker Carl,Batille Ivan,Berger Brian,Boyer David,Bridges William,Brooks Harold,Brown David,Chang Margaret,Chao Daniel,Chen Sanford,Crawford Courtney,Dugel Pravin,Eaton Alexander,Eichenbaum David,Fein Jordana,Feiner Leonard,Flaxel Christina,Garber Frank,Gordon Alan,Gupta Sunil,Haegedorn Curtis,Hampton George,Hanscom Thomas,Hershberger Vrinda,Kaiser Peter,Katz Randy,Khanani Arshad,Kruger Erik,Marcus Denis,Ohr Matthew,Patel Sunil,Pearlman Joel,Pesavento Richard,Pieramici Dante,Pitcher John,Prensky Jay,Randolf John,Regillo Carl,Rose Steven,Samuel Michael,Schneiderman Todd,Shah Sumit,Singer Michael,Steinle Nathan,Stoller Glenn,Thach Alan,Thompson John,Varenhorst Michael,Wagner Alan,Walker Joseph,Wells John,Williams Jonathan,Wong Robert,Wykoff Charles

Publisher

Elsevier BV

Subject

Ophthalmology

Reference34 articles.

1. Leading causes of certifiable visual loss in England and Wales during the year ending 31 March 2013;Quartilho;Eye,2016

2. Novel Drug Approvals for 2015,2022

3. 1 Recommendations | Faricimab for treating wet age-related macular degeneration | Guidance,2022

4. Pegaptanib for neovascular age-related macular degeneration;Gragoudas;N Engl J Med,2004

5. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3